Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Feasibility and Acceptability of the Co-administration of Ivermectin and Albendazole vs Albendazole Alone, in the Frame of Mass Drug Administration to School-aged Children in Uganda: A Small-scale Implementation Pilot Study

NCT06497075 is registered in ClinicalTrials.gov with Jennifer Keiser as lead sponsor.

NCT NCT06497075
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06497075 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Feasibility and Acceptability of the Co-administration of Ivermectin and Albendazole vs Albendazole Alone, in the Frame of Mass Drug Administration to School-aged Children in Uganda: A Small-scale Implementation Pilot Study
Lead sponsor
Jennifer Keiser
Phase
Observational
Overall status
Completed
Start date
July 1, 2024
Completion date
October 19, 2024
Enrollment
8,767 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

helminthiasis, intestinal worms